Abstract
As well as improving diagnostic and clinical outcomes for affected patients, understanding the genetic basis of rare human metabolic disorders has resulted in several fundamental biological insights. In some cases understanding extreme phenotypes has also informed thinking about more prevalent metabolic diseases. Insulin resistance underpins the twin epidemics of obesity and type 2 diabetes as well as accounting for many of the metabolic problems encompassed by the term metabolic syndrome. This review provides a brief update on current understanding of human severe insulin resistance syndromes, before highlighting recent insights provided by studies in these rare syndromes into the molecular pathogenesis of elements of the metabolic syndrome.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Acanthosis Nigricans / diagnosis
-
Adiponectin / blood
-
Diabetes Mellitus, Type 2 / genetics
-
Dyslipidemias / diagnosis
-
Fatty Liver
-
Female
-
Humans
-
Hyperinsulinism / physiopathology
-
Hypoglycemia / diagnosis
-
Insulin Resistance / genetics*
-
Lipogenesis / physiology
-
Metabolic Syndrome / genetics
-
Metabolic Syndrome / metabolism*
-
Mitochondrial Diseases / genetics
-
Mitochondrial Diseases / physiopathology
-
Non-alcoholic Fatty Liver Disease
-
Obesity / genetics
-
Phenotype
-
Phosphatidylinositol 3-Kinase / metabolism
-
Polycystic Ovary Syndrome / diagnosis
-
Proto-Oncogene Proteins c-akt / physiology
-
Receptor, IGF Type 1 / physiology
-
Signal Transduction / physiology
Substances
-
Adiponectin
-
Phosphatidylinositol 3-Kinase
-
Receptor, IGF Type 1
-
Proto-Oncogene Proteins c-akt